Genedx Holdings Corp Stock Retained Earnings
| WGS Stock | 101.60 0.35 0.34% |
Fundamental analysis of GeneDx Holdings allows traders to better anticipate movements in GeneDx Holdings' stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Retained Earnings | -1.4 B | -1.3 B | |
| Retained Earnings Total Equity | -1 B | -1.1 B |
GeneDx | Retained Earnings | Build AI portfolio with GeneDx Stock |
GeneDx Holdings Corp Company Retained Earnings Analysis
GeneDx Holdings' Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current GeneDx Holdings Retained Earnings | (1.35 B) |
Most of GeneDx Holdings' fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GeneDx Holdings Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
GeneDx Retained Earnings Driver Correlations
Understanding the fundamental principles of building solid financial models for GeneDx Holdings is extremely important. It helps to project a fair market value of GeneDx Stock properly, considering its historical fundamentals such as Retained Earnings. Since GeneDx Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GeneDx Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GeneDx Holdings' interrelated accounts and indicators.
Click cells to compare fundamentals
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, GeneDx Holdings Corp has a Retained Earnings of (1.35 Billion). This is 245.22% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The retained earnings for all United States stocks is 114.5% higher than that of the company.
GeneDx Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GeneDx Holdings' direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GeneDx Holdings could also be used in its relative valuation, which is a method of valuing GeneDx Holdings by comparing valuation metrics of similar companies.GeneDx Holdings is currently under evaluation in retained earnings category among its peers.
GeneDx Holdings Current Valuation Drivers
We derive many important indicators used in calculating different scores of GeneDx Holdings from analyzing GeneDx Holdings' financial statements. These drivers represent accounts that assess GeneDx Holdings' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of GeneDx Holdings' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 611.0M | 482.0M | 89.2M | 66.9M | 2.1B | 1.0B |
GeneDx Holdings ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, GeneDx Holdings' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to GeneDx Holdings' managers, analysts, and investors.Environmental | Governance | Social |
GeneDx Fundamentals
| Return On Equity | 0.006 | ||||
| Return On Asset | 0.0105 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 2.9 B | ||||
| Shares Outstanding | 28.73 M | ||||
| Shares Owned By Insiders | 12.46 % | ||||
| Shares Owned By Institutions | 87.55 % | ||||
| Number Of Shares Shorted | 3.48 M | ||||
| Price To Book | 10.53 X | ||||
| Price To Sales | 8.06 X | ||||
| Revenue | 305.45 M | ||||
| Gross Profit | 243.42 M | ||||
| EBITDA | (27.64 M) | ||||
| Net Income | (52.29 M) | ||||
| Total Debt | 116.17 M | ||||
| Book Value Per Share | 9.65 X | ||||
| Cash Flow From Operations | (28.5 M) | ||||
| Short Ratio | 3.55 X | ||||
| Earnings Per Share | 0.08 X | ||||
| Target Price | 113.86 | ||||
| Number Of Employees | 1 K | ||||
| Beta | 2.08 | ||||
| Market Capitalization | 2.92 B | ||||
| Total Asset | 419.38 M | ||||
| Retained Earnings | (1.35 B) | ||||
| Working Capital | 143.15 M | ||||
| Net Asset | 419.38 M |
About GeneDx Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GeneDx Holdings Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeneDx Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeneDx Holdings Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.